Effects of ciclosporin therapy on xylazine/ketamine anaesthesia in a rat model.
Loeffelbein
D J
DJ
Department of Oral and Maxillofacial Surgery, Technische Universität München, München, Germany. loeffelbein@mkg.med.tum.de
Nieberler
M
M
Steinstraesser
L
L
Boeckmann
R
R
Hoelzle
F
F
Wolff
K-D
KD
Kesting
M R
MR
D000316:Adrenergic alpha-Agonists / Q000493:pharmacokinetics / Q000494:pharmacology; D000778:Anesthetics, Dissociative / Q000493:pharmacokinetics / Q000494:pharmacology; D000818:Animals; D016572:Cyclosporine / Q000493:pharmacokinetics* / Q000494:pharmacology; D004347:Drug Interactions; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D007649:Ketamine / Q000493:pharmacokinetics* / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014991:Xylazine / Q000493:pharmacokinetics* / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000778:Anesthetics, Dissociative; D007166:Immunosuppressive Agents; D014991:Xylazine; D007649:Ketamine; D016572:Cyclosporine